![]() |
市場調査レポート
商品コード
1467591
PET-CTスキャナ装置市場レポート:タイプ、スライス数、アイソトープと検出器タイプ、サービスプロバイダー、用途、地域別、2024~2032年PET-CT Scanner Device Market Report by Type, Slice Count, Isotope and Detector Type, Service Provider, Application, and Region 2024-2032 |
||||||
カスタマイズ可能
|
PET-CTスキャナ装置市場レポート:タイプ、スライス数、アイソトープと検出器タイプ、サービスプロバイダー、用途、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
|
PET-CTスキャナ装置の世界市場規模は2023年に22億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに31億米ドルに達し、2024~2032年の間に3.62%の成長率(CAGR)を示すと予測しています。同市場は、ライフスタイルの変化や環境要因によるがん罹患率の上昇、画像診断の品質・効率・患者の安全性向上につながる技術革新の進展、高齢者人口の増加などを背景に安定した成長を遂げています。
市場の成長と規模医療インフラの改善、先進イメージング技術への投資の増加により、市場は着実に成長しています。
技術の進歩:人工知能(AI)アルゴリズムとマルチモーダルイメージング機能の統合により、診断能力の拡大とワークフローの合理化が進んでいます。
産業応用:PET-CTスキャナは心臓血管や神経疾患に応用されています。
地理的動向:アジア太平洋が市場をリードしており、これは新設病院、診断センター、専門クリニックの増加によるものです。しかし北米は、早期診断の利点に対する個人の意識の高まりにより、急成長市場として浮上しています。
競合情勢:主要企業は研究開発(R&D)活動に投資し、画像処理能力、診断精度、患者の快適性を向上させた革新的なPET-CTスキャナ技術を開発しています。
課題と機会:初期コストの高さなどの課題に直面する一方で、PET-CTイメージングの用途拡大という好機にも遭遇しています。
将来の展望:PET-CTスキャナ装置市場の将来は、個人の医療ニーズが進化していることから有望です。さらに、コンパクトで持ち運び可能なPET-CTスキャナの市場開拓が進むことで、PoCイメージングが可能になり、市場成長が促進されると予想されます。
がん患者の増加
世界中の大衆の間でがんの有病率が増加していることが、PET-CTスキャナ装置市場の成長を後押ししています。PET-CTスキャナは、がんの診断、病期分類、治療モニタリングにおいて極めて重要な役割を果たしています。PET-CTイメージングによる早期発見は、治療効果と患者の転帰を向上させ、PET-CTスキャナの普及に寄与しています。さらに、医療プロバイダーは、疾患の正確な特徴付けと個別化された治療計画のためにPET-CTスキャンへの依存度を高めています。これらの試験では、がん細胞に選択的に取り込まれる放射性医薬品が利用されるため、腫瘍内の代謝活動が可視化されます。一方、CTスキャンは詳細な解剖学的画像を提供し、PETで検出された異常な代謝活性の位置を正確に特定するのに役立ちます。PET-CT試験から得られる包括的な情報は、腫瘍内科医が手術、放射線療法、化学療法、標的療法などの治療戦略について、十分な情報に基づいた決定を下す際に役立ちます。さらに、PET-CT試験は迅速な治療開始を可能にし、患者の転帰を改善する可能性があります。がんと闘うために高度な診断ツールへのアクセスを改善する必要性が高まっています。
技術の進歩
PET-CTスキャナの技術革新は、画像診断の質、効率、患者の安全性の向上に役立っています。最新のPET-CTスキャナは空間分解能が高く、小さな病変も鮮明に描出でき、腫瘍の検出と特徴付けの精度が向上しています。この進歩により、早期の診断とより正確な治療計画が可能になります。さらに、最新のPET-CTスキャナはスキャン時間が短いため、患者の不快感を軽減し、医療現場でのワークフロー効率を高めることができます。迅速な画像取得により、臨床医は時間枠内でより多くのスキャンを実施することが可能となり、患者のスループット向上と資源利用の改善につながります。さらに、PET-CT技術の進歩により、診断画質を維持しながら放射線量を低減したスキャナが開発されつつあります。これらのスキャナは安全性を向上させ、患者への放射線被曝を最小限に抑えることで、繰り返しの画像試験に伴う長期的な副作用のリスクを低減します。これとは別に、呼吸ゲーティングやモーショントラッキングなどの高度な動き補正技術を採用したPET-CTスキャナは、より鮮明でアーチファクトのない画像を保証します。
高齢者人口の増加
世界の高齢者人口の増加によるPET-CTスキャナ装置への需要の高まりは、市場にプラスの影響を与えています。高齢者はがん、アルツハイマー病、心血管障害、その他の慢性疾患にかかりやすく、病気を正確に検出・監視する高度な装置が必要とされています。PET-CTスキャナは、心機能、心筋灌流、バイアビリティの包括的な評価を可能にし、高齢者患者の心血管疾患の診断と管理に役立ちます。さらに、加齢は神経変性疾患のリスク増大と関連しています。PET-CTイメージングにより、脳代謝、アミロイド沈着、神経受容体結合に関する貴重な知見が得られ、高齢者の早期診断や疾患モニタリングが容易になります。これとは別に、高齢者患者には複数の合併症があることが多く、総合的な診断評価が必要となります。PET-CTスキャナはマルチモーダルイメージング機能を備えており、1回の試験で複数の臓器系を同時に評価することができます。この統合的アプローチは、診断ワークフローを合理化し、高齢者の複雑な健康状態を管理する際の臨床的意思決定を強化する上で有益です。
The global PET-CT scanner device market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032. The market is experiencing stable growth driven by rising prevalence of cancer due to lifestyle changes and environmental factors, increasing technological innovations that are leading to enhanced imaging quality, efficiency, and patient safety, and the growing geriatric population.
Market Growth and Size: The market is witnessing steady growth on account of the improving healthcare infrastructure, along with rising investments in advanced imaging technologies.
Technological Advancements: Integration of artificial intelligence (AI) algorithms and multimodal imaging capabilities is augmenting diagnostic capabilities and streamlining workflows.
Industry Applications: PET-CT scanner devices find applications in cardiovascular and neurological disorders.
Geographical Trends: Asia Pacific leads the market, driven by the rising number of new hospitals, diagnostic centers, and specialty clinics. However, North America is emerging as a fast-growing market due to the increasing awareness among individuals about the benefits of early diagnoses.
Competitive Landscape: Key players are investing in research and development (R&D) activities to develop innovative PET-CT scanner technologies with improved imaging capabilities, enhanced diagnostic accuracy, and patient comfort.
Challenges and Opportunities: While the market faces challenges, such as high initial costs, it also encounters opportunities on account of the expanding applications of PET-CT imaging.
Future Outlook: The future of the PET-CT scanner device market looks promising, with the evolving healthcare needs among individuals. Furthermore, the rising development of compact and portable PET-CT scanners will enable PoC imaging, which is anticipated to bolster the market growth.
Rising prevalence of cancer cases
The increasing prevalence of cancer among the masses around the world is propelling the PET-CT scanner device market growth. PET-CT scanners play a pivotal role in cancer diagnosis, staging, and treatment monitoring. Early detection through PET-CT imaging enhances treatment efficacy and patient outcomes, contributing to its widespread adoption. Moreover, healthcare providers are increasingly relying on PET-CT scans for accurate disease characterization and personalized treatment planning. These scans utilize radiopharmaceuticals that are selectively taken up by cancer cells, allowing for the visualization of metabolic activity within tumors. Meanwhile, CT scans provide detailed anatomical images that help precisely locate abnormal metabolic activity detected by PET. The comprehensive information obtained from PET-CT scans aids oncologists in making informed decisions regarding treatment strategies, including surgery, radiation therapy, chemotherapy, and targeted therapies. In addition, PET-CT scans enable prompt initiation of treatment and potentially improve patient outcomes. There is a rise in the need for improved access to advanced diagnostic tools to fight against cancer.
Technological advancements
Innovations in PET-CT scanners assist in enhancing imaging quality, efficiency, and patient safety. Modern PET-CT scanners feature higher spatial resolution that allows for clearer visualization of small lesions and improved accuracy in tumor detection and characterization. This advancement enables earlier diagnosis and more precise treatment planning. Moreover, advanced PET-CT scanners offer shorter scan times that benefit in reducing patient discomfort and enhancing workflow efficiency in healthcare settings. Rapid image acquisition enables clinicians to perform more scans in a time frame, leading to increased patient throughput and improved resource utilization. Furthermore, advancements in PET-CT technology are leading to the development of scanners with lower radiation doses while maintaining diagnostic image quality. These scanners improve safety and reduce the risk of long-term adverse effects associated with repeated imaging studies by minimizing radiation exposure to patients. Apart from this, PET-CT scanners employed with advanced motion correction techniques, such as respiratory gating and motion tracking, ensure sharper and artifact-free images.
Increasing geriatric population
The growing demand for PET-CT scanner devices due to rising geriatric population worldwide is positively influencing the market. Elderly individuals are more susceptible to cancer, Alzheimer's disease, cardiovascular disorders, and other chronic diseases, necessitating advanced devices that detect and monitor diseases accurately. PET-CT scanners enable comprehensive assessment of cardiac function, myocardial perfusion, and viability, aiding in the diagnosis and management of cardiovascular conditions in geriatric patients. Moreover, aging is associated with an increased risk of neurodegenerative disorders. PET-CT imaging provides valuable insights into brain metabolism, amyloid deposition, and neuroreceptor binding that facilitate early diagnosis and disease monitoring in elderly individuals. Apart from this, geriatric patients often have multiple comorbidities, requiring comprehensive diagnostic evaluations. PET-CT scanners offer multimodal imaging capabilities, allowing for simultaneous assessment of multiple organ systems in a single examination. This integrated approach benefits in streamlining diagnostic workflows and enhancing clinical decision-making in managing complex health conditions in the elderly.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, slice count, isotope and detector type, service provider, and application.
Stationary Scanners
Portable Scanners/Mobile Scanners
Stationary scanners account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes stationary scanners and portable scanners/mobile scanners. According to the report, stationary scanners represented the largest segment.
Low Slice Scanner (<64 Slices)
Medium Slice Scanner (64 Slices)
High Slice Scanner (>64 Slices)
Medium slice scanner (64 slices) holds the largest market share
A detailed breakup and analysis of the market based on the slice count have also been provided in the report. This includes low slice scanner (<64 slices), medium slice scanner (64 slices), and high slice scanner (>64 slices). According to the report, medium slice scanner (64 slices) accounted for the largest market share.
Flurodeoxyglucose (FDG)
62Cu ATSM
FMISO
Gallium
Thallium
Others
Flurodeoxyglucose (FDG) represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the isotope and detector type. This includes flurodeoxyglucose (FDG), 62Cu ATSM, 18 F sodium fluoride, FMISO, gallium, thallium, and others. According to the report, flurodeoxyglucose (FDG) represented the largest segment.
Hospitals
Diagnostic Centers
Research Institutes
Hospitals exhibit a clear dominance in the market
The report has provided a detailed breakup and analysis of the market based on the service provider. This includes hospitals, diagnostic centers, and research institutes. According to the report, hospitals represented the largest segment.
Oncology
Neurology
Cardiology
Others
Oncology dominates the market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, neurology, cardiology, and others. According to the report, oncology represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific leads the market, accounting for the largest PET-CT scanner device market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share due to the presence of well-established new hospitals, diagnostic centers, and specialty clinics. In addition, the rising prevalence of cancer among individuals in the region is bolstering the market growth.
Bruker Corporation
Canon Medical Systems Usa Inc.
General Electric Company
Hitachi Ltd.
Koninklijke Philips N.V.
Mediso Ltd.
Neusoft Corporation
Positron Corporation
Shimadzu Corporation
Siemens Healthcare GmbH (Siemens AG)
Sofie Biosciences Inc.
United Imaging Healthcare Co. Ltd.
Yangzhou Kindsway Biotech Co. Ltd.